December 2, 2020Complex markers of survival from pembrolizumab: The potential predictive role of tumor mutational burden (TMB) and KRAS Read more »
May 15, 2023Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assay Read more »
December 1, 2020PD-L1 by RNA next generation sequencing: Comparison with PD-L1 IHC 22C3 and association with survival benefit from pembrolizumab with or without chemotherapy in non-small cell lung cancer Read more »
January 9, 2020TCR convergence in individuals treated with immune checkpoint inhibition for cancer Read more »
June 20, 2020Tumor inflammatory signature as a biomarker of response to immunotherapy in lung cancer Read more »
May 25, 2021Visceral obesity promotes lung cancer progression – towards resolution of the obesity paradox in lung cancer Read more »
November 1, 2021Molecular profiling of metastatic renal cell carcinoma treated with ipilimumab-nivolumab Read more »
